Due: 2024-03 Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells

Due: March 15, 2024

The purpose of this Notice of Funding Opportunity (NOFO) is to support the late-stage engineering and preclinical development of innovative biological products that safely and specifically kill HIV-infected cells. Products of interest include but are not limited to broadly neutralizing antibodies (bNAbs), their derivatives, and other soluble, antibody-like molecules.